These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom. Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537 [TBL] [Abstract][Full Text] [Related]
3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
4. [Changing Trends in Isolation Frequencies and Species of Clinical Fungal Strains: What Do the 12-years (2008-2019) Mycology Laboratory Data Tell About?]. Gülmez D; Sığ AK; Akar N; Duyan S; Arıkan Akdağlı S Mikrobiyol Bul; 2021 Jan; 55(1):53-66. PubMed ID: 33590981 [TBL] [Abstract][Full Text] [Related]
5. Fungal susceptibility testing: where are we now? Patterson TF Transpl Infect Dis; 2002; 4 Suppl 3():38-45. PubMed ID: 12486791 [TBL] [Abstract][Full Text] [Related]
6. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance. Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605 [TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
8. [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing]. Gadea I; Cuenca-Estrella M; Martín E; Pemán J; Pontón J; Rodríguez-Tudela JL Enferm Infecc Microbiol Clin; 2007 May; 25(5):336-40. PubMed ID: 17504688 [TBL] [Abstract][Full Text] [Related]
9. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections. Clark NM; Grim SA; Lynch JP Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542 [TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility testing. New technology and clinical applications. Pfaller MA; Yu WL Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273 [TBL] [Abstract][Full Text] [Related]
16. Antifungal Resistance: An Emerging Reality and A Global Challenge. Kontoyiannis DP J Infect Dis; 2017 Aug; 216(suppl_3):S431-S435. PubMed ID: 28911044 [No Abstract] [Full Text] [Related]
17. Development and validation of a molecular method for the diagnosis of medically important fungal infections. De Marco D; Perotti M; Ossi CM; Burioni R; Clementi M; Mancini N New Microbiol; 2007 Jul; 30(3):308-12. PubMed ID: 17802916 [TBL] [Abstract][Full Text] [Related]
18. Emerging Diagnostics and Therapeutics for Invasive Fungal Infections. Friedman DZP; Schwartz IS Infect Dis Clin North Am; 2023 Sep; 37(3):593-616. PubMed ID: 37532392 [TBL] [Abstract][Full Text] [Related]
19. New antifungal agents. Gupta AK; Tomas E Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208 [TBL] [Abstract][Full Text] [Related]